AKTS 8-K 2026-01-12

Aktis Oncology, Inc. (AKTS) 8-K dated 2026-01-12 — accession 0001193125-26-010354. This URL is the filing, not the AKTS hub.

Aktis Oncology, Inc. (AKTS) common stock.

Aktis Oncology, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-010354.

Cached items: 5.03, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AKTS revenue for 2026-06-30 was $6.6M. Net income was -$42.5M.

Not investment advice. The AKTS SEC hub lists recent forms. The stock page is the research view.